DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,790,290 | +3.1% | 7,216 | -0.2% | 0.64% | +13.1% |
| Q2 2023 | $1,735,680 | -52.4% | 7,232 | -50.0% | 0.56% | -10.5% |
| Q1 2023 | $3,645,506 | +85.5% | 14,464 | +95.3% | 0.63% | -10.8% |
| Q4 2022 | $1,965,701 | -0.5% | 7,406 | -3.1% | 0.71% | -3.9% |
| Q3 2022 | $1,975,000 | +2.9% | 7,646 | +1.0% | 0.74% | +6.7% |
| Q2 2022 | $1,919,000 | -13.0% | 7,568 | +0.7% | 0.69% | +4.9% |
| Q1 2022 | $2,205,000 | -50.8% | 7,518 | -44.8% | 0.66% | -47.6% |
| Q4 2021 | $4,483,000 | +11.6% | 13,625 | +3.3% | 1.25% | -0.4% |
| Q3 2021 | $4,017,000 | +13.5% | 13,195 | +0.1% | 1.26% | +21.2% |
| Q2 2021 | $3,538,000 | +18.3% | 13,183 | -0.8% | 1.04% | +11.6% |
| Q1 2021 | $2,990,000 | +1.5% | 13,288 | +0.2% | 0.93% | -10.9% |
| Q4 2020 | $2,945,000 | +3.2% | 13,258 | 0.0% | 1.04% | -12.6% |
| Q3 2020 | $2,855,000 | +20.6% | 13,258 | -1.0% | 1.19% | +21.1% |
| Q2 2020 | $2,367,000 | +18.8% | 13,386 | -7.0% | 0.99% | -0.5% |
| Q1 2020 | $1,992,000 | -9.8% | 14,389 | 0.0% | 0.99% | +5.8% |
| Q4 2019 | $2,208,000 | +6.3% | 14,389 | +0.1% | 0.94% | +1.7% |
| Q3 2019 | $2,077,000 | +4.6% | 14,378 | +3.5% | 0.92% | +7.8% |
| Q2 2019 | $1,986,000 | +7.5% | 13,894 | -0.7% | 0.85% | +6.4% |
| Q1 2019 | $1,847,000 | +33.7% | 13,994 | +4.5% | 0.80% | +21.5% |
| Q4 2018 | $1,381,000 | -5.8% | 13,396 | -0.7% | 0.66% | +15.0% |
| Q3 2018 | $1,466,000 | +11.0% | 13,489 | +0.7% | 0.58% | +2.5% |
| Q2 2018 | $1,321,000 | -3.3% | 13,389 | -4.0% | 0.56% | -7.7% |
| Q1 2018 | $1,366,000 | +5.1% | 13,949 | -0.4% | 0.61% | +8.8% |
| Q4 2017 | $1,300,000 | +8.2% | 14,004 | -0.1% | 0.56% | +2.0% |
| Q3 2017 | $1,202,000 | +1.6% | 14,014 | 0.0% | 0.55% | -1.4% |
| Q2 2017 | $1,183,000 | -0.7% | 14,014 | +0.6% | 0.56% | -8.9% |
| Q1 2017 | $1,191,000 | +7.5% | 13,926 | -2.2% | 0.61% | +19.4% |
| Q4 2016 | $1,108,000 | +0.6% | 14,236 | +1.4% | 0.51% | -5.2% |
| Q3 2016 | $1,101,000 | -22.8% | 14,042 | -0.5% | 0.54% | -24.2% |
| Q2 2016 | $1,426,000 | +6.9% | 14,117 | +0.4% | 0.71% | +6.0% |
| Q1 2016 | $1,334,000 | -11.1% | 14,059 | -13.0% | 0.67% | -17.5% |
| Q4 2015 | $1,501,000 | +9.2% | 16,163 | +0.2% | 0.81% | +11.1% |
| Q3 2015 | $1,375,000 | +0.8% | 16,132 | +1.2% | 0.73% | +8.6% |
| Q2 2015 | $1,364,000 | +297.7% | 15,937 | +298.4% | 0.67% | +294.2% |
| Q4 2014 | $343,000 | +12.8% | 4,000 | 0.0% | 0.17% | +8.2% |
| Q3 2014 | $304,000 | -3.5% | 4,000 | 0.0% | 0.16% | +2.6% |
| Q2 2014 | $315,000 | +5.0% | 4,000 | 0.0% | 0.15% | -3.8% |
| Q1 2014 | $300,000 | -2.9% | 4,000 | 0.0% | 0.16% | -2.4% |
| Q4 2013 | $309,000 | +11.6% | 4,000 | 0.0% | 0.16% | +1.9% |
| Q3 2013 | $277,000 | -37.5% | 4,000 | -42.9% | 0.16% | -50.8% |
| Q2 2013 | $443,000 | – | 7,000 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |